The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Lueke Melissa since 2006.
The trader's CIK number is 1224663.
At the time of the last reporting, Lueke Melissa was the VP, CFO of Meridian Bioscience Inc. (stock ticker symbol VIVO).
Also see all insider trading activities at Meridian Bioscience Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | VIVO | 4,000 | $50,356 | 0 | $0 | 0 | $0 |
| 2015 | VIVO | 0 | $0 | 0 | $0 | 15,750 | $220,610 |
| 2014 | VIVO | 0 | $0 | 6,713 | $108,750 | 10,500 | $76,440 |
| 2012 | VIVO | 0 | $0 | 21,000 | $416,644 | 21,000 | $0 |
| 2010 | VIVO | 0 | $0 | 22,500 | $530,235 | 22,500 | $0 |
| 2007 | VIVO | 0 | $0 | 33,563 | $862,756 | 29,813 | $126,307 |
| 2006 | VIVO | 0 | $0 | 0 | $0 | 15,000 | $25,005 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-02-02 | VIVO | Buy | 4,000 | 12.59 | 50,356 |
| 2015-11-05 | VIVO | Option Ex | 15,750 | 14.01 | 220,610 |
| 2014-11-18 | VIVO | Option Ex | 10,500 | 7.28 | 76,440 |
| 2014-11-18 | VIVO | Sale | 6,713 | 16.20 | 108,750 |
| 2012-12-13 | VIVO | Sale | 5,250 | 19.88 | 104,385 |
| 2012-12-14 | VIVO | Sale | 15,750 | 19.83 | 312,259 |
| 2012-12-13 | VIVO | Option Ex | 21,000 | .00 | 0 |
| 2010-12-13 | VIVO | Sale | 22,500 | 23.57 | 530,235 |
| 2010-11-15 | VIVO | Option Ex | 22,500 | .00 | 0 |
| 2007-10-16 | VIVO | Option Ex | 11,250 | 3.19 | 35,943 |
| 2007-07-24 | VIVO | Option Ex | 18,563 | 4.87 | 90,364 |
| 2007-07-24 | VIVO | Sale | 18,563 | 22.96 | 426,206 |
| 2007-01-24 | VIVO | Sale | 5,000 | 29.10 | 145,500 |
| 2007-01-25 | VIVO | Sale | 5,000 | 29.10 | 145,500 |
| 2007-01-26 | VIVO | Sale | 5,000 | 29.11 | 145,550 |
| 2006-11-03 | VIVO | Option Ex | 15,000 | 1.67 | 25,005 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lueke Melissa (VP, CFO of Meridian Bioscience Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.